搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
vktx
/
财务摘要
Viking Therapeutics Inc
VKTX
添加自选
29.950
USD
-1.580
-5.01%
收盘 09-15 16:00(美东)
3.49B
总市值
亏损
市盈率 TTM
Viking Therapeutics Inc
29.950
-1.580
-5.01%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
VKTX 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Viking Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
3.49B
股息TTM
0.00
市盈率 TTM
-7.21
每股收益TTM
-4.15
营业收入
0.00
净利润
-109.96M
净资产收益率
-70.04%
总资产收益率
-64.04%
Viking Therapeutics Inc 财报日历
最新发布
7月 29, 2026
每股收益 / 预测值
-1.10
/-1.25
营业收入 / 预测值
0.00
/0.00
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-88.34%
-1.10
-236.48%
-1.37
-334.80%
-1.38
-259.46%
-0.81
-190.07%
-0.58
-53.98%
-0.41
-29.18%
-0.32
0.37%
-0.22
-3.81%
-0.20
-6.08%
-0.26
3.60%
-0.25
--
-0.23
--
-0.19
--
-0.25
--
-0.26
--
-0.64
--
--
--
--
--
--
--
--
营业收入
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
净利润
-95.27%
-128.02M
-246.98%
-158.32M
-345.16%
-157.66M
-264.02%
-90.79M
-194.66%
-65.56M
-66.80%
-45.63M
-43.94%
-35.42M
-10.68%
-24.94M
-15.73%
-22.25M
-40.06%
-27.36M
-25.80%
-24.61M
-42.86%
-22.53M
-10.29%
-19.23M
-21.29%
-19.53M
-58.30%
-19.56M
-19.10%
-15.77M
-13.33%
-17.43M
-14.94%
-16.10M
-12.86%
-12.36M
-42.58%
-13.24M
利润表
营业收入
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
营业利润
-77.81%
-132.60M
-195.89%
-164.13M
-256.28%
-164.74M
-169.62%
-98.56M
-118.99%
-74.57M
-62.79%
-55.47M
-57.89%
-46.24M
-34.08%
-36.56M
-43.45%
-34.05M
-65.91%
-34.07M
-44.38%
-29.29M
-68.34%
-27.27M
-34.65%
-23.74M
-26.42%
-20.54M
-62.13%
-20.28M
-20.84%
-16.20M
-13.45%
-17.63M
-14.18%
-16.25M
-11.04%
-12.51M
-36.17%
-13.40M
净利润
-95.27%
-128.02M
-246.98%
-158.32M
-345.16%
-157.66M
-264.02%
-90.79M
-194.66%
-65.56M
-66.80%
-45.63M
-43.94%
-35.42M
-10.68%
-24.94M
-15.73%
-22.25M
-40.06%
-27.36M
-25.80%
-24.61M
-42.86%
-22.53M
-10.29%
-19.23M
-21.29%
-19.53M
-58.30%
-19.56M
-19.10%
-15.77M
-13.33%
-17.43M
-14.94%
-16.10M
-12.86%
-12.36M
-42.58%
-13.24M
资产负债表
流动资产
-37.42%
517.56M
-29.77%
608.21M
-21.12%
715.60M
-21.13%
738.70M
-12.55%
827.02M
-10.38%
866.02M
147.05%
907.22M
145.65%
936.65M
136.80%
945.72M
546.52%
966.34M
119.84%
367.23M
130.89%
381.30M
122.04%
399.37M
-22.68%
149.47M
-20.66%
167.04M
-26.37%
165.15M
-24.32%
179.86M
-22.64%
193.30M
-17.80%
210.53M
-14.76%
224.28M
流动负债总额
242.89%
109.66M
443.22%
106.33M
179.67%
76.67M
1.49%
26.07M
27.45%
31.98M
-40.28%
19.57M
43.26%
27.41M
91.61%
25.68M
86.18%
25.09M
109.43%
32.77M
-12.81%
19.14M
-4.67%
13.40M
-9.32%
13.48M
38.88%
15.65M
150.02%
21.95M
23.85%
14.06M
15.48%
14.86M
-12.76%
11.27M
-27.63%
8.78M
16.86%
11.35M
总资产
-36.96%
521.90M
-29.84%
608.24M
-21.20%
715.73M
-21.16%
739.41M
-12.57%
827.85M
-10.39%
866.99M
146.50%
908.32M
145.10%
937.89M
136.30%
946.84M
541.19%
967.52M
118.65%
368.49M
129.58%
382.66M
120.76%
400.69M
-22.63%
150.90M
-20.00%
168.53M
-25.75%
166.68M
-23.69%
181.51M
-22.03%
195.03M
-17.87%
210.66M
-14.85%
224.47M
总负债
250.67%
113.58M
429.64%
106.33M
173.39%
76.67M
-0.21%
26.39M
25.26%
32.39M
-40.30%
20.07M
39.72%
28.04M
83.32%
26.44M
77.38%
25.86M
99.80%
33.63M
-13.51%
20.07M
-6.33%
14.42M
-10.44%
14.58M
31.92%
16.83M
164.38%
23.21M
35.63%
15.40M
26.47%
16.28M
-1.22%
12.76M
-27.80%
8.78M
15.49%
11.35M
总权益
-48.67%
408.32M
-40.74%
501.92M
-27.40%
639.06M
-21.77%
713.03M
-13.63%
795.46M
-9.31%
846.92M
152.65%
880.28M
147.51%
911.45M
138.52%
920.98M
596.60%
933.89M
139.76%
348.42M
143.41%
368.24M
133.68%
386.12M
-26.45%
134.06M
-28.02%
145.32M
-29.01%
151.28M
-26.56%
165.23M
-23.17%
182.27M
-17.38%
201.88M
-16.03%
213.12M
现金流量表
经营净额
-165.98%
-125.17M
-117.80%
-113.98M
-173.53%
-85.29M
-328.03%
-94.00M
-65.05%
-47.06M
-753.13%
-52.33M
-76.76%
-31.18M
-11.72%
-21.96M
-149.35%
-28.51M
75.11%
-6.13M
-61.45%
-17.64M
-45.63%
-19.66M
14.93%
-11.44M
-134.03%
-24.64M
11.53%
-10.93M
-23.55%
-13.50M
-0.06%
-13.44M
3.18%
-10.53M
-125.12%
-12.35M
-105.26%
-10.93M
投资净额
157.45%
109.43M
-14.32%
54.19M
1048.42%
75.61M
517.83%
160.03M
133.72%
42.51M
113.76%
63.24M
-81.57%
6.58M
306.65%
25.90M
38.35%
-126.06M
-21018.65%
-459.79M
392.19%
35.73M
-146.61%
-12.53M
-1177.36%
-204.48M
35.76%
2.20M
-73.51%
7.26M
97.50%
26.89M
433.15%
18.98M
124.43%
1.62M
-9.45%
27.41M
241.34%
13.62M
融资净额
4552.07%
23.59M
3360.46%
12.08M
7410.30%
75.10M
-80.97%
480.00K
-82.55%
507.00K
-99.94%
349.00K
431.91%
1.00M
3508.11%
2.52M
-98.91%
2.91M
14384.63%
606.04M
-98.25%
188.00K
-840.00%
-74.00K
16897.36%
267.08M
183.58%
4.18M
22770.21%
10.75M
103.91%
10.00K
-183.77%
-1.59M
-196.44%
-5.01M
-89.87%
47.00K
-791.89%
-256.00K
常见问题
Viking Therapeutics Inc的流动资产是多少?
根据Viking Therapeutics Inc的FY2025财报,流动资产为715.60M(同比变化-21.12)。
Viking Therapeutics Inc的总资产是多少?
根据Viking Therapeutics Inc的FY2025财报,Viking Therapeutics Inc的总资产为715.73M(同比变化-21.20)。
Viking Therapeutics Inc的总负债是多少?
根据Viking Therapeutics Inc的FY2025财报,Viking Therapeutics Inc的总负债为76.67M(同比变化173.39)。
Viking Therapeutics Inc的总权益是多少?
根据Viking Therapeutics Inc的FY2025财报,Viking Therapeutics Inc的总权益为639.06M(同比变化-27.40)。
Viking Therapeutics Inc的净营业收入是多少?
根据Viking Therapeutics Inc的FY2025财报,Viking Therapeutics Inc的净营业收入为-393.34M(同比变化-160.63)。
Viking Therapeutics Inc的净投资是多少?
根据Viking Therapeutics Inc的FY2025财报,Viking Therapeutics Inc的净投资为341.39M(同比变化161.69)。
Viking Therapeutics Inc的净融资是多少?
根据Viking Therapeutics Inc的FY2025财报,Viking Therapeutics Inc的净融资为76.44M(同比变化-87.52)。
Viking Therapeutics Inc的每股收益(EPS)是多少?
根据Viking Therapeutics Inc的FY2025财报,每股收益(EPS)为-3.19(同比变化-216.52)。
Viking Therapeutics Inc的净利润是多少?
根据Viking Therapeutics Inc的FY2025财报,净利润为-359.64M(同比变化-227.05)。
Viking Therapeutics Inc的股东权益回报率(ROE)是多少?
根据Viking Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-47.34(同比变化-164.49)。
Viking Therapeutics Inc的资产回报率(ROA)是多少?
根据Viking Therapeutics Inc的FY2025财报,资产回报率(ROA)为-44.29(同比变化-157.13)。
Viking Therapeutics Inc的营业利润是多少?
根据Viking Therapeutics Inc的FY2025财报,营业利润为-393.34M(同比变化-160.63)。